Tag:
LifeCycle Pharma
Latest Headlines
Latest Headlines
LifeCycle shares soar after low-dose organ rejection drug edges Prograf in Ph3
In a head-to-head study with a market leading treatment designed to prevent kidney transplant rejection, Denmark's LifeCycle Pharma says that its once-daily experimental drug edged out Astellas's
